In vitro to Clinical Translation of Combinatorial Effects of Doxorubicin and Abemaciclib in Rb-Positive Triple Negative Breast Cancer: A Systems-Based Pharmacokinetic/Pharmacodynamic Modeling Approach

JOURNAL ARTICLE published February 2021 in Breast Cancer: Targets and Therapy

Authors: Brett Fleisher | Jovin Lezeau | Carolin Werkman | Brehanna Jacobs | Sihem Ait-Oudhia